Cargando…
Mechanism of Albuminuria Reduction by Chymase Inhibition in Diabetic Mice
Chymase has several functions, such as angiotensin II formation, which can promote diabetic kidney disease (DKD). In this study, we evaluated the effect of the chymase inhibitor TY-51469 on DKD in diabetic db/db mice. Diabetic mice were administered TY-51469 (10 mg/kg/day) or placebo for 4 weeks. No...
Autores principales: | Terai, Kentaro, Jin, Denan, Watase, Kenji, Imagawa, Akihisa, Takai, Shinji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589797/ https://www.ncbi.nlm.nih.gov/pubmed/33050674 http://dx.doi.org/10.3390/ijms21207495 |
Ejemplares similares
-
Chymase inhibition retards albuminuria in type 2 diabetes
por: Bivona, Benjamin J., et al.
Publicado: (2019) -
Pathophysiological Role of Chymase-Activated Matrix Metalloproteinase-9
por: Takai, Shinji, et al.
Publicado: (2022) -
Chymase as a Possible Therapeutic Target for Amelioration of Non-Alcoholic Steatohepatitis
por: Takai, Shinji, et al.
Publicado: (2020) -
Chymase Inhibitor as a Novel Therapeutic Agent for Non-alcoholic Steatohepatitis
por: Takai, Shinji, et al.
Publicado: (2018) -
Chymase as a Novel Therapeutic Target in Acute Pancreatitis
por: Kuramoto, Toru, et al.
Publicado: (2021)